
As healthcare systems grow increasingly connected, the risk of medical device vulnerabilities expands with it. This joint whitepaper by Medcrypt and The AbedGraham Group provides a clinically informed, patient safety–driven approach to evaluating and prioritizing vulnerabilities in connected medical devices. Using real-world use cases and quantitative analytics, it demonstrates how technical flaws like Ripple20 and BlueKeep translate into tangible clinical, operational, financial, and regulatory risks—and offers a framework for mitigation that aligns with both cybersecurity and patient safety objectives.
Traditional vulnerability scoring systems (e.g., CVSS) don’t capture the real-world clinical impact of a cyber event. A vulnerability that seems minor on paper could disrupt patient care, while others may be less impactful than headlines suggest. This paper reframes vulnerability management through a patient safety lens, helping both manufacturers and healthcare delivery organizations prioritize threats based on how they affect clinical workflows and outcomes—not just technical severity.